Package Leaflet: Information for the User
Sapropterina Dipharma 100 mg Powder for Oral Solution
Sapropterina Dipharma 500 mg Powder for Oral Solution
sapropterin dihydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Sapropterina Dipharma contains the active substance sapropterin, which is a synthetic copy of a substance naturally found in the body called tetrahydrobiopterin (BH4). BH4 is necessary in the body to convert an amino acid called phenylalanine into another amino acid called tyrosine.
Sapropterina Dipharma is used to treat hyperphenylalaninemia (HPA) or phenylketonuria (PKU) in patients of any age. HPA and PKU are due to abnormally high levels of phenylalanine in the blood that can be harmful. Sapropterina Dipharma reduces these levels in some patients who respond to BH4 and may help increase the amount of phenylalanine that can be included in the diet.
This medicine is also used to treat a hereditary disease called BH4 deficiency in patients of any age, in which the body cannot produce enough BH4. Because BH4 levels are very low, the body cannot properly use phenylalanine and levels of this amino acid increase, having harmful effects. By replacing the BH4 that the body cannot produce, Sapropterina Dipharma reduces the harmful excess of phenylalanine in the blood and increases tolerance to dietary phenylalanine.
Do not take Sapropterina Dipharma
Warnings and precautions
Consult your doctor or pharmacist before starting treatment with Sapropterina Dipharma, especially:
When you receive treatment with Sapropterina Dipharma, your doctor will perform blood tests to check the content of phenylalanine and tyrosine and decide whether to adjust the dose of Sapropterina Dipharma or the diet if necessary.
You must continue dietary treatment as recommended by your doctor. Do not change your diet without telling your doctor. Even if you take Sapropterina Dipharma, if your blood phenylalanine levels are not well controlled, you may have serious neurological problems. Your doctor must continue to monitor your blood phenylalanine levels frequently during treatment with Sapropterina Dipharma, to ensure they are not too high or too low.
Using Sapropterina Dipharma with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. In particular, you should tell your doctor if you are using:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
If you are pregnant, your doctor will tell you how to properly control phenylalanine levels. If they are not strictly controlled before pregnancy or when you become pregnant, it can be harmful to you and your baby. Your doctor will monitor dietary restriction of phenylalanine intake before and during pregnancy.
If a strict diet does not satisfactorily reduce the amount of phenylalanine in the blood, your doctor will consider whether you should take this medicine.
You should not use this medicine during breastfeeding.
Driving and using machines
Sapropterina Dipharma is not expected to affect your ability to drive or use machines.
Sapropterina Dipharma contains potassium
Sapropterina Dipharma 100 mg powder for oral solution
This medicine contains 0.3 mmol (11.7 mg) of potassium per sachet, which should be taken into account in patients with renal insufficiency or in patients with low-potassium diets.
Sapropterina Dipharma 500 mg powder for oral solution
This medicine contains 1.6 mmol (62.6 mg) of potassium per sachet, which should be taken into account in patients with renal insufficiency or in patients with low-potassium diets.
Follow exactly the administration instructions of this medicine given by your doctor. If you are unsure, consult your doctor again.
Sapropterina Dipharma 500 mg should only be used in patients with a body weight over 25 kg.
Dose for PKU
The recommended initial dose of Sapropterina Dipharma in patients with PKU is 10 mg per kg of body weight. Take Sapropterina Dipharma once a day, with a meal to increase absorption, and at the same time each day, preferably in the morning. Your doctor may adjust the dose, usually between 5 and 20 mg daily per kg of body weight, according to your condition.
Dose for BH4 deficiency
The recommended initial dose of Sapropterina Dipharma in patients with BH4 deficiency is 2 to 5 mg per kg of body weight. Take Sapropterina Dipharma with a meal to increase absorption. Divide the total daily dose into 2 or 3 doses administered throughout the day. Your doctor may adjust the dose up to 20 mg daily per kg of body weight, according to your condition.
The following table is an example of how to calculate the appropriate dose
Body weight (kg) | Number of 100 mg sachets (dose of 10 mg/kg) | Number of 100 mg sachets (dose of 20 mg/kg) | Number of 500 mg sachets (dose of 10 mg/kg) | Number of 500 mg sachets (dose of 20 mg/kg) |
10 | 1 | 2 | - | - |
20 | 2 | 4 | - | - |
30 | 3 | 6 | - | - |
40 | 4 | 8 | - | - |
50 | 5 | 10 | 1 | 2 |
Method of administration
For patients with PKU, the total daily dose is taken once a day and at the same time each day, preferably in the morning.
For patients with BH4 deficiency, the total daily dose is divided into 2 or 3 doses distributed throughout the day.
Use in patients with a body weight over 20 kg
Make sure you know the dose of Sapropterina Dipharma powder that your doctor has prescribed.
Sapropterina Dipharma 100 mg powder for oral solution
For higher doses, your doctor may also prescribe Sapropterina Dipharma 500 mg powder for oral solution.
Sapropterina Dipharma 500 mg powder for oral solution
For the exact dose, your doctor may also prescribe Sapropterina Dipharma 100 mg powder for oral solution.
Make sure you know how to use Sapropterina Dipharma 100 mg or 500 mg powder for oral solution or both medicines to prepare the dose.
Open the sachet (or sachets) only when you are about to use it (them).
Preparation of the sachet (or sachets)
Intake of the medicine
Use in children up to 20 kg body weight
Use only the 100 mg sachets if you are preparing Sapropterina Dipharma for children with a body weight of up to 20 kg.
The dose is based on body weight, which will change as the child grows. Your doctor will tell you:
The child should drink the Sapropterina Dipharma solution with a meal.
Administer the prescribed amount of solution to the child within 3 minutes of dissolution. If you cannot administer the dose to the child within 30 minutes of dissolving the powder, you will need to prepare a new solution, as the unused solution should not be used after 30 minutes.
Materials needed to prepare and administer the dose of Sapropterin Dipharma to the child
Ask your doctor for the medicine cup and the 10 ml or 20 ml oral syringe if you do not have these materials.
Steps for preparation and intake of the dose:
If you take more Sapropterina Dipharma than you should
If you take more Sapropterina Dipharma than prescribed, you may experience side effects that can include headache and dizziness. If you take more Sapropterina Dipharma than prescribed, tell your doctor or pharmacist immediately.
If you forget to take Sapropterina Dipharma
Do not take a double dose to make up for forgotten doses. Take the next dose at the usual time.
If you stop taking Sapropterina Dipharma
Do not stop treatment with Sapropterina Dipharma without discussing it with your doctor first, as blood phenylalanine levels may increase.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
There have been a few reports of allergic reactions (such as skin rash and severe reactions). The frequency is not known (frequency cannot be estimated from the available data).
If you have inflamed, reddened, and severely itchy areas (hives), runny nose, rapid or irregular heartbeat, swelling of the tongue or throat, sneezing, wheezing, severe breathing difficulties, or dizziness, you may be experiencing a severe allergic reaction to the medicine. If you experience these symptoms, consult your doctor immediately.
Very common side effects (may affect more than 1 in 10 people)
Headache and runny nose.
Common side effects (may affect up to 1 in 10 people)
Sore throat, nasal congestion or stuffiness, cough, diarrhea, vomiting, stomach pain, low phenylalanine levels in blood tests, indigestion, and general discomfort (nausea) (see section 2: "Warnings and precautions").
Unknown frequency (cannot be estimated from the available data)
Gastritis (inflammation of the stomach lining), esophagitis (inflammation of the esophagus lining).
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the sachet and on the carton after EXP. The expiry date refers to the last day of the month shown.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Sapropterina Dipharma
Sapropterina Dipharma 100 mg:Each sachet contains 100 mg of sapropterin dihydrochloride (equivalent to 77 mg of sapropterin).
Sapropterina Dipharma 500 mg:Each sachet contains 500 mg of sapropterin dihydrochloride (equivalent to 384 mg of sapropterin).
Appearance and packaging
The powder for oral solution is white to yellowish in color. The powder is in single-dose sachets containing 100 mg or 500 mg of sapropterin dihydrochloride.
Packs of 30 sachets.
Marketing Authorisation Holder
Dipharma Arzneimittel GmbH
Offheimer Weg 33
65549 Limburg a. d. Lahn
Germany
Manufacturer
Depo-Pack S.r.l.
Via Giovanni Morandi 28
21047 Saronno (VA)
Italy
or
Pharmadox Healthcare Ltd.
KW20A Kordin Industrial Park
Paola, PLA 3000
Malta
Date of last revision of this leaflet:
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu. There are also links to other websites on rare diseases and orphan medicines.